Author

Hideaki Kato

Yokohama City University HospitalORCID 0000-0002-7853-5721Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Akihide RyoiD· 1 shared Atsushi GotoiD· 1 shared Hideaki NakajimaiD· 1 shared Hideki HasegawaiD· 1 shared Hiroshi YotsuyanagiiD· 1 shared Kaori SanoiD· 1 shared Kei MiyakawaiD· 1 shared Kiyoko Iwatsuki‐HorimotoiD· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Akihide RyoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyVaccinePeer-reviewedNov 5, 2024

Neutralizing antibody evasion of SARS-CoV-2 JN.1 derivatives KP.3, KP.3.1.1, LB.1, and XEC

Kaori Sano, Kei Miyakawa, Hideaki Kato…·Hideki Hasegawa

The paper evaluates neutralizing antibody responses against SARS-CoV-2 JN.1 variants in vaccinated individuals, finding significant immune escape by some variants but robust cross-neutralization by JN.1-based immunization.

7 citations

humanexperimental assay

𝕏 PostBluesky

MicrobiologyCell ReportsPeer-reviewedDec 1, 2023

Characterization of an EG.5.1 clinical isolate in vitro and in vivo

Ryuta Uraki, Maki Kiso, Kiyoko Iwatsuki‐Horimoto…·Yoshihiro Kawaoka

This study characterizes the in vitro and in vivo properties of the EG.5.1 SARS-CoV-2 variant, showing increased transmissibility and altered antigenicity compared to XBB.1.5.

30 citationstop 3%

mouseexperimental assay

𝕏 PostBluesky